Healthpeak Properties (NYSE:DOC) Issues FY 2026 Earnings Guidance

Healthpeak Properties (NYSE:DOC) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.730-1.770 for the period, compared to the consensus EPS estimate of 1.750. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Citigroup increased their price objective on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday, May 12th. Mizuho lifted their target price on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, July 6th. JPMorgan Chase & Co. increased their price objective on Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. UBS Group boosted their target price on Healthpeak Properties from $19.00 to $21.50 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Finally, Scotiabank boosted their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a report on Wednesday, May 27th. Four analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the stock. According to data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Hold” and an average price target of $20.62.

Healthpeak Properties Stock Performance

NYSE DOC traded up $0.23 on Wednesday, hitting $21.84. 3,450,835 shares of the company traded hands, compared to its average volume of 8,604,323. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The business’s 50 day moving average price is $21.08 and its 200-day moving average price is $18.73. The company has a market capitalization of $15.06 billion, a price-to-earnings ratio of 68.12, a P/E/G ratio of 3.36 and a beta of 1.01. Healthpeak Properties has a 52-week low of $15.70 and a 52-week high of $22.95.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. The firm had revenue of $771.58 million for the quarter, compared to analysts’ expectations of $725.64 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The business’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Equities analysts expect that Healthpeak Properties will post 1.75 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be paid a $0.1017 dividend. This represents a c) dividend on an annualized basis and a yield of 5.6%. The ex-dividend date is Monday, September 14th. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.23% of the stock is owned by insiders.

Hedge Funds Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently modified their holdings of the stock. Wedbush Securities Inc. bought a new position in Healthpeak Properties during the fourth quarter valued at $170,000. Federated Hermes Inc. increased its holdings in Healthpeak Properties by 252.9% during the 4th quarter. Federated Hermes Inc. now owns 10,482 shares of the real estate investment trust’s stock worth $169,000 after purchasing an additional 7,512 shares during the period. Binnacle Investments Inc lifted its holdings in shares of Healthpeak Properties by 19.2% in the 2nd quarter. Binnacle Investments Inc now owns 8,247 shares of the real estate investment trust’s stock worth $144,000 after buying an additional 1,327 shares during the period. UMB Bank n.a. increased its stake in shares of Healthpeak Properties by 62.5% during the fourth quarter. UMB Bank n.a. now owns 7,470 shares of the real estate investment trust’s stock valued at $120,000 after buying an additional 2,873 shares during the period. Finally, Transamerica Financial Advisors LLC grew its holdings in Healthpeak Properties by 98.2% during the 4th quarter. Transamerica Financial Advisors LLC now owns 6,111 shares of the real estate investment trust’s stock worth $98,000 after acquiring an additional 3,027 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.